You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab

 

Online download statistics by month:

Online download statistics by month: June 2020 to April 2023

AbstractFullPdf
Jun 2020273273116
Jul 202010910946
Aug 2020393917
Sep 202011911929
Oct 2020808049
Nov 2020787820
Dec 2020787818
Jan 202114514541
Feb 202110410417
Mar 202113913924
Apr 202111711722
May 2021767628
Jun 2021555510
Jul 2021676721
Aug 2021757510
Sep 2021505014
Oct 2021515129
Nov 2021737324
Dec 2021717119
Jan 2022626617
Feb 2022373716
Mar 2022727314
Apr 2022788013
May 202212812819
Jun 2022555610
Jul 2022596012
Aug 2022565616
Sep 2022444422
Oct 2022727216
Nov 2022454716
Dec 202253535
Jan 202347479
Feb 2023848417
Mar 202369739
Apr 2023474717
Total28072822782